Butterfly Network (NYSE:BFLY) shares performed impressively today on second-quarter results that topped the consensus forecast. BFLY shares closed the day up 12.1% at $11.70 and continued to tick up after hours, rising 0.9% at $11.80. MassDevice’s MedTech 100 Index — which includes stocks of the world’s largest medical device companies — closed the day down […]
Digital Health
iRhythm beats The Street in Q2, expects up to 23% revenue growth this year
iRhythm Technologies (NASDAQ: IRTC) posted second-quarter results that beat the consensus forecast on Wall Street. The San Francisco–based company — maker of the Zio Patch for ambulatory cardiac monitoring — reported a loss of –$17.4 million, or –59¢ per share, on sales of $81.3 million for the quarter ended June 30, 2021. Revenue was up […]
FDA clears Medtronic’s AI algorithms for cardiac monitoring
Medtronic (NYSE:MDT) announced today that the FDA cleared two of its AccuRhythm AI algorithms for use with the Linq II ICM. Fridley, Minn.–based Medtronic’s AccuRhythm AI applies artificial intelligence to heart rhythm event data collected by the Linq II insertable cardiac monitor (ICM) to improve the information provided to physicians for better diagnoses and treatments […]
How COVID-19 changed medical device clinical trials forever
The success of remote clinical trial oversight opens the door to hybrid approaches and creates new possibilities for the future of trials. DeviceTalks Because of the pandemic, virtually overnight, all players involved in medical device clinical trials had to pivot to virtual monitoring to keep trials going. What impact did remote trial oversight have on […]
The 18 most innovative medical devices of 2021
The Galien Foundation today announced the nominees for most innovative medical devices for its 15th annual Prix Galien USA Awards. The foundation nominates devices, biotechnology and pharmaceutical products for its annual Prix Galien awards to highlight products designed to improve the human condition. “The Awards Committee is excited to introduce the nominees for the 2021 […]
Pear Therapeutics touts 9-month data for reSET-O
Pear Therapeutics today touted results from an extended retrospective analysis of real-world data for its reSET-O prescription digital therapeutic. Boston-based Pear Therapeutics developed its reSET-O prescription digital therapeutic (PDT) for treating opioid use disorder (OUD). Get the full story at our sister site, Drug Delivery Business News.
Glytec appoints chief medical officer
Cloud-based insulin management software developer Glytec announced today that it appointed Dr. Jordan Messler as chief medical officer. Messler’s responsibilities as the company’s CMO include spearheading continuous improvement initiatives for Glytec’s clinical strategy and product development. Get the full story at our sister site, Drug Delivery Business News.
Augmedics adds J&J, Stryker veterans to board leadership
Augmedics announced that it appointed Rick Anderson as executive chairman of its board and Bradley Paddock as the board’s independent director. Chicago-based Augmedics said yesterday in a news release that Anderson joined the board in March upon the closing of Augmedics’ oversubscribed $36 million Series C financing round. Paddock then joined in May and both […]
Explorer Surgical expands offerings into robotic surgery space
Explorer Surgical announced today that will expand its cloud-based digital platform into the robotic surgery space. As a result of the foray into surgical robotics, medical robotics companies will now be able to leverage the Explorer Live digital platform and procedural playbook, video capabilities and data collection offerings to improve workflow and performance. Get the […]
DarioHealth touts data for diabetes management platform
DarioHealth (NSDQ:DRIO) recently presented data supporting its artificial intelligence (AI)-powered diabetes management platform. New York-based Dario’s research examined users who were given access to a new product experience designed to drive better health habits and behaviors through its AI-driven personalization engine. Get the full story at our sister site, Drug Delivery Business News.
Viz.ai wins CE mark for AI-powered stroke care software
Viz.ai announced today that it received CE mark approval for its flagship Viz LVO AI-based stroke care software platform. San Francisco–based Viz.ai developed Viz LVO to use AI to automatically detect suspected large vessel occlusion (LVO) strokes on computed tomography angiography (CTA) imaging. Once the platform detects stroke, it directly alerts on-call stroke specialists about […]